Jennifer Arena

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

Jessica L. Chitty, Michelle Yam, Lara Perryman et al. · Nature Cancer · 2023 · 124 citations · Full text

Medicine, Oncology, Pharmacology +13

ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors

Angela Chou, Malinda Itchins, Philip R. de Reuver et al. · Human Pathology · 2018 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +11

DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association

Vanessa Lakis, Rita T. Lawlor, Felicity Newell et al. · Communications Biology · 2021 · 52 citations · Full text

Medicine, Genetics, Oncology +17

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer

Sarah Maloney, Nick Pavlakis, Malinda Itchins et al. · Journal of Clinical Medicine · 2023 · 43 citations · Full text

Medicine, Oncology, Pathology +17

Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre

Malinda Itchins, Jennifer Arena, Christopher B. Nahm et al. · European Journal of Surgical Oncology · 2017 · 32 citations · Full text

Medicine, Oncology, Surgery +11